A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: A controlled trial

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 11, 2004, Pages 997-1002

  Bilardi, Claudio ^a   Dulbecco, Pietro ^a   Zentilin, Patrizia ^a   Reglioni, Simona ^a   Iiritano, Elena ^a   Parodi, Andrea ^a   Accornero, Laura ^a   Savarino, Edoardo ^a   Mansi, Carlo ^a   Mamone, Mario ^a   Vigneri, Sergio ^b   Savarino, Vincenzo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RATE; MALE; MEDICAL ASSESSMENT; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; UPPER GASTROINTESTINAL TRACT; UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OFLOXACIN; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; SULFOXIDES; TREATMENT OUTCOME;

EID: 9144258031     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00458-6     Document Type: Article

References (34)

1. D.Y. Graham, G.M. Lew, P.D. Klein, D.G. Evans, D.J. Evans Jr, Z.A. Saeed, H.M. Malaty Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer a randomized controlled study Ann Intern Med 116 1992 705 708
2. J.J. Sung, S.C. Chung, T.K. Ling, M.Y. Yung, V.K. Leung, E.K. Ng, M.K. Li, A.F. Cheng, A.K. Li Antibacterial treatment of gastric ulcer associated with Helicobacter pylori N Engl J Med 332 1995 139 142
3. A.C. Wotherspoon, C. Doglioni, M. de Boni, J. Spencer, P.G. Isaacson Antibiotic treatment for low-grade gastric MALT lymphoma Lancet 11 1994 1503
4. P. Malfertheiner, F. Mégraud, C. O'Morain, A.P. Hungin, R. Jones, A. Axon, D.Y. Graham, G. Tytgat European Helicobacter pylori Study Group (EHPSG) Current concepts in the management of Helicobacter pylori infection--the Maastrict 2-2000 Consensus Report Aliment Pharmacol Ther 16 2002 167 180
5. J.P. Gisbert, J.M. Pajares Review article Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail Aliment Pharmacol Ther 16 2002 1047 1057
6. F. Parente, C. Cucino, G. Bianchi Porro Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts Dig Liver Dis 35 2003 523 528
7. D.Y. Graham, G.M. Lew, H.M. Malaty, D.G. Evans, D.J. Evans Jr, P.D. Klein, L.C. Alpert, R.M. Genta Factors influencing the eradication of Helicobacter pylori with triple therapy Gastroenterology 102 1992 493 496
8. M.H. Houben, D. Van Der Beek, E.F. Hensen, A.J. Craen, E.A. Rauws, G.N. Tytgat A systematic review of Helicobacter pylori eradication therapy. The impact of antimicrobial resistance on eradication rates Aliment Pharmacol Ther 13 1999 1047 1055
9. F. Mégraud, H. Lamouliatte Review article the treatment of refractory Helicobacter pylori infection Aliment Pharmacol Ther 17 2003 1333 1343
10. M.S. Osato, R. Reddy, S.G. Reddy, R.L. Penland, H.M. Malaty, D.Y. Graham Pattern of primary resistance of Helicobacter pylori to metronidazole and clarithromycin in the United States Arch Intern Med 161 2001 1217 1220
11. E.J. Van Der Wouden, J.C. Thijs, A.A. Van Zwet, J.H. Kleibeuker Review article nitroimidazole resistance in Helicobacter pylori Aliment Pharmacol Ther 14 2000 7 14
12. B.J. McMahon, T.W. Hennessy, J.M. Bensler, D.L. Bruden, A.J. Parkinson, J.M. Morris, A.L. Reasonover, D.A. Hurlburt, M.G. Bruce, F. Sacco, J.C. Butler The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infection Ann Intern Med 139 2003 463 469
13. R.J. Adamek, S. Sauerbaum, B. Pfaffenbach, W. Opferkuch Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxicillin influence on treatment outcome Am J Gastroenterol 93 1998 386 389
14. S. Toracchio, L. Marzio Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002 Dig Liver Dis 35 2003 541 545
15. D.Y. Graham Antibiotic resistance in Helicobacter pylori implications for therapy Gastroenterology 115 1998 1272 1277
16. V. Savarino, M. Neri, S. Vigneri PPI-based triple therapy in the eradication of Helicobacter pylori infection Gastroenterology 117 1999 746 747
17. P.H. Kathelaris, G.M. Forbes, N.J. Talley, B. Crotty A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication. The QUADRATE study Gastroenterology 123 2002 1763 1769
18. F. Mégraud, B.J. Marshall How to treat Helicobacter pylori. First-line, second-line and future therapies Gastroenterol Clin North Am 29 2000 759 773
19. F. Perri, V. Festa, R. Clemente, M.R. Villani, M. Quitadamo, N. Caruso, M.I. Bergoli, A. Andriulli Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies Am J Gastroenterol 96 2001 58 62
20. G. Treiber, S. Ammon, P. Malfertheiner, U. Klotz Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures Helicobacter 7 2002 225 231
21. F. Canducci, V. Ojetti, P. Pola, G. Gasbarrini, A. Gasbarrini Rifabutin-based Helicobacter pylori eradication "rescue therapy." Aliment Pharmacol Ther 15 2001 143
22. H. Fakheri, S. Merat, V. Hosseini, R. Malekzadeh Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication Aliment Pharmacol Ther 19 2004 89 93
23. J.E. Sanchez, N.G. Saenz, M.R. Rincon, I.T. Martin, E.G. Sanchez, M.J. Martinez Susceptibility of Helicobacter pylori to mupirocin, oxazolidones, quinupristin/dalfopristin and new quinolones J Antimicrob Chemother 46 2000 283 285
24. G. Cammarota, R. Cianci, O. Cannizzaro, L. Cuoco, G. Dirozzi, A. Gasbarrini, A. Armuzzi, M.A. Zocco, L. Santarelli, F. Arancio, G. Gasbarrini Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection Aliment Pharmacol Ther 14 2000 1339 1343
25. S. Di Caro, M. Assunta Zocco, F. Cremonini, M. Candelli, E.C. Nista, F. Bartolozzi, A. Armuzzi, G. Cammarota, L. Santarelli, A. Gasbarrini Levofloxacin-based regimens for the eradication of Helicobacter pylori Eur J Gastroenterol Hepatol 14 2002 1309 1312
26. E.C. Nista, M. Candelli, F. Cremonini, A. Cazzato, S. Di Caro, M. Gabrielli, L. Santarelli, M.A. Zocco, V. Ometti, E. Carboni, G. Cammarota, G. Gasbarrini, A. Gasbarrini Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment a randomized trial Aliment Pharmacol Ther 18 2003 627 633
27. Y. Watanabe, N. Aoyama, D. Shirasaka, S. Maekawa, K. Kuroda, I. Miki, M. Kachi, M. Fukuda, C. Wambura, T. Tamura, M. Kasuga Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy Dig Liver Dis 35 2003 711 715
28. A. Zullo, C. Hassan, V. De Francesco, R. Lorenzetti, M. Marignani, S. Angeletti, E. Ierardi, S. Morini A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication Dig Liver Dis 35 2003 232 236
29. V. Savarino, P. Zentilin, M. Pivari, G. Bisso, M.R. Mele, C. Bilardi, P. Borro, P. Dulbecco, L. Tessieri, C. Mansi, G. Borgonovo, L. De Salvo, S. Vigneri The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori Aliment Pharmacol Ther 14 2000 893 900
30. 13C-urea breath test Am J Gastroenterol 94 1999 1203 1208
31. F. Perri, V. Festa, R. Clemente, M. Quitadamo, A. Andriulli Rifabutin-based "rescue therapy" for Helicobacter pylori infected patients after failure of standard regimens Aliment Pharmacol Ther 14 2000 311 316
32. H. Fakheri, R. Malekzadeh, S. Merat, M. Khatibian, A. Fazel, B.Z. Alizadeh, S. Massarrat Clarithromycin versus furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate Aliment Pharmacol Ther 15 2001 411 416
33. J. Cabrita, M. Oleastro, R. Matos, A. Manhente, J. Cabral, R. Barros, A.I. Lopes, P. Ramalho, B.C. Neves, A.S. Guerreiro Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) J Antimicrob Chemother 46 2000 1029 1031
34. M.P. Dore, D.Y. Graham, R. Mele, L. Marras, S. Nieddu, A. Manca, G. Realdi Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection Am J Gastroenterol 97 2002 857 860